Monterotondo, Italy

Gianluca Rinaldi

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 42(Granted Patents)


Location History:

  • Monterotondo, RO (2019)
  • Monterotondo, IT (2014 - 2023)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gianluca Rinaldi

Introduction

Gianluca Rinaldi is a prominent inventor based in Monterotondo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid compositions for drug delivery. With a total of 13 patents to his name, Rinaldi's work is paving the way for advancements in medication stability and accessibility.

Latest Patents

One of Rinaldi's latest patents focuses on a novel liquid pharmaceutical composition of adalimumab. This composition includes adalimumab or a biosimilar, a histidine buffering agent, and a sugar stabilizer such as trehalose. The combination of these components results in formulations that exhibit stability comparable to or better than existing options, while using fewer ingredients. This innovation aims to make adalimumab treatments more widely available at a lower cost and prolong the viability of pre-loaded delivery devices, such as pre-filled syringes, thereby reducing unnecessary waste of the drug.

Career Highlights

Throughout his career, Gianluca Rinaldi has worked with notable companies in the pharmaceutical industry, including Fresenius Kabi Deutschland GmbH and Ares Trading S.A. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Rinaldi has collaborated with several professionals in his field, including Alessandra Del Rio and Silvia Fratarcangeli. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Gianluca Rinaldi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations and accessibility. His work continues to influence the industry positively, making significant strides in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…